Most Popular
Weekly Gene
【Gene of the Week】DMD: Duchenne Muscular Dystrophy Pathogenic Gene
Jul 02, 2021
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration. It usually starts in early childhood. Read More >
Newsletter
Examples of Gene Therapy Treatments for Rare Diseases
Jun 18, 2021
This article will introduce the current research progress and case analysis of gene therapies for rare diseases. Read More >
Newsletter
CGT
What are the Strategies for Gene Therapy?
Jun 18, 2021
Gene therapy refers to the introduction of exogenous (normal) genes into target cells to correct or compensate for the diseases caused by defects and abnormal genes, to achieve the purpose of disease treatment. Read More >
Newsletter
What is Gene Therapy? An Introduction to the Research
Jun 18, 2021
Gene therapy is designed to treat diseases by introducing exogenous DNA or RNA into human target cells, which may be achieved by a few different methods. Read More >
Newsletter
What are Knockout Cell Lines Used For?
Jun 17, 2021
As an easy-to-use and powerful gene-editing tool, CRISPR-Pro has been widely used in applications ranging from basic research to the treatment of genetic diseases. The development of this technology has made the generation of knockout (KO) cell line models more accessible. Why use knockout cell lines? In this article, we review the various applications of the knockout cell lines, hoping to bring some inspiration for your research. Read More >
Newsletter
Video
Expert Webinar: Introduction to Genetically Engineered Rodent Models
Jun 15, 2021
View our Expert Webinar to learn about cutting-edge genome editing technologies and application limitations of animal models - such as genetically modified mice and rats. Read More >
Newsletter
Exhibiting at International Society for Stem Cell Research (ISSCR) 2021
Jun 11, 2021
Cyagen Biosciences is looking forward to virtually exhibiting at the International Society for Stem Cell Research (ISSCR) Annual Meeting Read More >
Newsletter
Leveraging Humanized Mice for Human Antibody Discovery
Jun 08, 2021
With the rapid development of human antibody production, using gene editing technology to construct humanized mice with human antibodies has become an important subject in antibody drug discovery Read More >
Newsletter
Human Antibody Discovery Using In-vivo Mouse Models
Jun 08, 2021
The continuous development and improvement of gene editing technology has driven the successful establishment of such a platform for mouse models expressing human antibody genes Read More >
Newsletter
Important Considerations in the Humanization of Antibodies
Jun 08, 2021
The clinical application of mouse-derived antibodies has revealed some limitations, such as causing human anti-mouse antibody (HAMA) reaction, an allergic reaction that might accelerate clearance of mouse antibodies and cause anaphylaxis. Read More >